As of August 2026 — Disclosed Capitol has tracked 362 disclosed congressional trades in Abbott Laboratories (ABT) — 144:121 sell-heavy ratio — led by Ro Khanna (D).

Which members of Congress trade Abbott Laboratories?

• Ro Khanna (D) — 35 disclosed trades in ABT
• Michael McCaul (R) — 11 disclosed trades in ABT
• Josh Gottheimer (D) — 8 disclosed trades in ABT
• Richard Dean Dr McCormick (R) — 6 disclosed trades in ABT
• Gilbert Cisneros (D) — 5 disclosed trades in ABT

Recent ABT congressional trades

Buy vs. sell ratio & volume

Across the 362 disclosed congressional trades in Abbott Laboratories (ABT), members of Congress have reported 121 buys and 144 sells. The average 30-day alpha vs. the S&P 500 is 0.22%.

Does Abbott Laboratories receive U.S. government contracts?

As of August 2026, Abbott Laboratories has 3,143 federal contract award records on file from USAspending.gov — most recently $166K from the Department of Veterans Affairs on 2026-08-31.

Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.

Abbott Laboratories financial snapshot (FY2025)

For fiscal year 2025, Abbott Laboratories reported revenue of $44.33B and net income of $6.52B, per SEC filings.

Revenue

$44.33B

Operating income

$8.05B

Net income

$6.52B

Diluted EPS

$3.72

Net margin

14.7%

Free cash flow

$7.39B

Most recent reported quarter: Q1 FY2026 — revenue $11.16B, net income $1.08B.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.